Literature DB >> 26303111

Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child.

Alison Boast1, Jeremy Carr1, Nigel Curtis1,2,3, Andrew J Daley4, Amanda Gwee5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26303111     DOI： 10.1007/s00228-015-1928-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.

Authors:  R Nau; H W Prange; S Menck; H Kolenda; K Visser; J K Seydel
Journal:  J Antimicrob Chemother       Date:  1992-06       Impact factor: 5.790

2.  Practice guidelines for the management of bacterial meningitis.

Authors:  Allan R Tunkel; Barry J Hartman; Sheldon L Kaplan; Bruce A Kaufman; Karen L Roos; W Michael Scheld; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2004-10-06       Impact factor: 9.079

3.  Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.

Authors:  Joyce Pullen; Lindsay de Rozario; Leo M L Stolk; Pieter L J Degraeuwe; Frank H van Tiel; Luc J I Zimmermann
Journal:  Ther Drug Monit       Date:  2006-06       Impact factor: 3.681

4.  Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.

Authors:  Thomas P Lodise; Ben Lomaestro; George L Drusano
Journal:  Clin Infect Dis       Date:  2007-01-02       Impact factor: 9.079

5.  Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.

Authors:  Mohd H Abdul-Aziz; Craig McDonald; Brett McWhinney; Jacobus P J Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Ann Pharmacother       Date:  2014-06-20       Impact factor: 3.154

6.  Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.

Authors:  Susan McKamy; Elvin Hernandez; Maximillian Jahng; Tiffany Moriwaki; Audra Deveikis; Jennifer Le
Journal:  J Pediatr       Date:  2011-03       Impact factor: 4.406

Review 7.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

8.  In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.

Authors:  Patrick Grohs; Marie-Dominique Kitzis; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections.

Authors:  Huawei Huang; Shengyue Huang; Pengli Zhu; Xiuming Xi
Journal:  Int J Antimicrob Agents       Date:  2013-10-01       Impact factor: 5.283

10.  Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections.

Authors:  Julie Autmizguine; Cassie Moran; Daniel Gonzalez; Edmund V Capparelli; P Brian Smith; Gerald A Grant; Daniel K Benjamin; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Pediatr Infect Dis J       Date:  2014-10       Impact factor: 3.806
View more
  1 in total

1.  Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing.

Authors:  Eveline E Roelofsen; Brenda C M de Winter; Heleen van der Spek; Susan Snijders; Birgit C P Koch; Sanne van den Berg; Anouk E Muller
Journal:  Antibiotics (Basel)       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.